"Without question, BioAdvance funding was a critical ingredient for the launch of Melior Discovery. There was simply no comparable funding source for a startup entity such as ours. Melior would not exist today, would not have discovered a new class of candidate diabetes therapeutics, and would not have uncovered new clinical candidates for our pharma partners were it not for funding conduit provided by BioAdvance."
Andrew Reaume
President & CEO
Melior Discovery, Inc.
Exton, PA
Andrew Reaume
President & CEO
Melior Discovery, Inc.
Exton, PA
News Releases
| 2010 | | | 2009 | | | 2008 | | | 2007 | | | 2006 | | | 2005 | | | 2004 | | | 2003 | | | 2002 | | | 2001 |
2005
|
November 28, 2005 New Study Published in PNAS Confirms Potential Untility of Marillion's Nanoparticle Technology for Tumor Targeting Agents |
| > View Press Release |
|
November 8, 2005 BioAdvance Leads Seed Funding Round for Neurology Start-Up NuPathe Inc. |
| > View Press Release |
|
November 2, 2005 BioAdvance Portfolio Company Yaupon Therapeutics Named Best Life Sciences Start-Up |
| > View Press Release |
|
October 18, 2005 BioAdvance Names Ezra Felker As Entrepreneur-In-Residence |
| > View Press Release |
|
August 24, 2005 Protez Pharmaceuticals Closes $15 Million Financing |
| > View Press Release |
|
June 20, 2005 BioAdvance sponsors Milken Institute Study - Greater Philadelphia Among Top Three Life Sciences Clusters in Nation |
| > View Press Release |
|
January 24, 2005 BioAdvance Greenhouse Fund Invests $3.5 Million in New Regional Life Sciences Enterprises |
| > View Press Release |
|
January 6, 2005 RetinaPharma Announces FDA Clearance of Innovative Device to More Effectively Diagnose Glaucoma |
| > View Press Release |
© Copyright 2008. BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. All Rights Reserved.